To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

119th Congress

Introduced by Brian Babin, Jim Baird, Andy Biggs and 14 other co-sponsors

HR 679 nullifies recent FDA changes to mifepristone's risk evaluation strategy, limiting HHS's authority and potentially impacting access to medical abortion services.

Introduced in House

Repost

0Comment

0 views

Bill Summary • HR 679

Analyzing...

Hi! I'm your AI assistant for HR 679. I can help you understand its provisions, impacts, and answer any questions.

Key Provisions Impacts Timeline

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Sign in

Create your Account

Forgot your password?

Reset Your Password

Report Content

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Sign in

Create your Account

Forgot your password?

Reset Your Password

Report Content

Quote Repost

Action Required